Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription 08.04.2024 2 Ann Neurol 2 BMC Neurol 4 Intern Med 2 J Autoimmun 1 J Clin Endocrinol Metab 1 J Immunol 1 J Neuroimmunol 9 J Neurol 5 J Rheumatol 2 Kidney Int 2 Mult Scler 1 Neurologia (Engl Ed) 1 Neurology 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. CALABRESE M, Preziosa P, Scalfari A, Colato E, et al
   Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.
   Ann Neurol. 2024 Apr 3. doi: 10.1002/ana.26913.
   PubMed         Abstract available
   
   
2. NEIDHART S, Vlad B, Hilty M, Hogelin KA, et al
   HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis.
   Ann Neurol. 2024 Mar 29. doi: 10.1002/ana.26921.
   PubMed         Abstract available
   
   

   
   BMC Neurol

3. WANNINAYAKE L, Rajapaksha D, Nair N, Gunarathne K, et al
   Guillain-Barre syndrome of acute motor axonal neuropathy (AMAN) type associated with herpes zoster: a case report.
   BMC Neurol. 2024;24:109.
   PubMed         Abstract available
   
   
4. CARDENAS-ROBLEDO S, Arenas-Vargas LE, Arenas RD, Gaspar-Toro JM, et al
   Treatment patterns and persistence on disease modifying therapies for multiple sclerosis and its associated factors.
   BMC Neurol. 2024;24:108.
   PubMed         Abstract available
   
   

   
   Intern Med

5. ISOGAI S, Hayashi R, Naniwa T
   Nasal Septal Perforation and Widespread Skin Lesions caused by Mycobacterium chelonae Infection Mimicking Granulomatosis with Polyangiitis.
   Intern Med. 2023 Aug 9. doi: 10.2169/internalmedicine.2202.
   PubMed         Abstract available
   
   
6. IWATA F, Fukui S, Okada M
   Herpes Esophagitis Occurring after Immunosuppression with Glucocorticoids.
   Intern Med. 2024;63:1033-1034.
   PubMed        
   
   
7. MIZUTANI K, Sakurai K, Uchida Y, Hashimoto K, et al
   A case of autoimmune encephalitis in a patient with a solitary intracranial plasmacytoma.
   Intern Med. 2024 Apr 2. doi: 10.2169/internalmedicine.2888.
   PubMed         Abstract available
   
   
8. OKABAYASHI H, Nakashima S, Fujino K, Imai M, et al
   Tension Pneumomediastinum in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease: A Case Report and Literature Review.
   Intern Med. 2024 Apr 2. doi: 10.2169/internalmedicine.3418.
   PubMed         Abstract available
   
   

   
   J Autoimmun

9. BENDER C, Muller P, Tondello C, Horn J, et al
   Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes.
   J Autoimmun. 2023;143:103161.
   PubMed         Abstract available
   
   
10. ZHONG T, Li X, Lei K, Tang R, et al
    CXCL12-CXCR4 mediates CD57(+) CD8(+) T cell responses in the progression of type 1 diabetes.
    J Autoimmun. 2024;143:103171.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

11. VILLAGELIN D, Cooper DS, Burch HB
    A 2023 International Survey of Clinical Practice Patterns in the Management of Graves' Disease: A Decade of Change.
    J Clin Endocrinol Metab. 2024 Apr 5:dgae222. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Immunol

12. FRANK C, Salapa HE, Allen KJH, Levin MC, et al
    Antibody-Mediated Depletion of Autoreactive T Lymphocytes through PD-1 Improves Disease Outcomes and Visualizes T Cell Activation in Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2024 Apr 5:ji2300751. doi: 10.4049/jimmunol.2300751.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

13. SRIWASTAVA S, Elkhooly M, Amatya S, Shrestha K, et al
    Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis.
    J Neuroimmunol. 2024;390:578315.
    PubMed         Abstract available
    
    

    
    J Neurol

14. HUA T, Fan H, Duan Y, Tian D, et al
    Spinal cord and brain atrophy patterns in neuromyelitis optica spectrum disorder and multiple sclerosis.
    J Neurol. 2024 Apr 1. doi: 10.1007/s00415-024-12281.
    PubMed         Abstract available
    
    
15. GLASER A, Butzkueven H, van der Walt A, Gray O, et al
    Big Multiple Sclerosis Data network: an international registry research network.
    J Neurol. 2024 Apr 1. doi: 10.1007/s00415-024-12303.
    PubMed         Abstract available
    
    
16. GUERRIERI S, Rubin M, Gattuso I, Zanetta C, et al
    Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series.
    J Neurol. 2024 Apr 2. doi: 10.1007/s00415-024-12342.
    PubMed        
    
    
17. SIGNORIELLO E, Foschi M, Lanzillo R, Frau J, et al
    Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine.
    J Neurol. 2024 Apr 3. doi: 10.1007/s00415-024-12291.
    PubMed         Abstract available
    
    
18. MAIDA E, Moccia M, Palladino R, Borriello G, et al
    ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.
    J Neurol. 2024 Apr 3. doi: 10.1007/s00415-024-12328.
    PubMed         Abstract available
    
    
19. TERAYAMA A, Kuwahara M, Yoshikawa K, Yamagishi Y, et al
    Takotsubo cardiomyopathy in Guillain-Barre syndrome.
    J Neurol. 2024 Apr 4. doi: 10.1007/s00415-024-12295.
    PubMed         Abstract available
    
    
20. STEFANOU MI, Giannopapas V, Kitsos DK, Chondrogianni M, et al
    Prevalence and epidemiology of stroke in patients with multiple sclerosis: a systematic review and meta-analysis.
    J Neurol. 2024 Apr 4. doi: 10.1007/s00415-024-12331.
    PubMed         Abstract available
    
    
21. CELIK M, Baba C, Irmak C, Ozakbas S, et al
    Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey.
    J Neurol. 2024 Apr 5. doi: 10.1007/s00415-024-12333.
    PubMed         Abstract available
    
    
22. MARTINEZ-MARTINEZ L, Lacruz AC, Querol L, Cortes-Vicente E, et al
    Inter-laboratory comparison of routine autoantibody detection methods for autoimmune neuropathies and myasthenia gravis.
    J Neurol. 2024 Apr 5. doi: 10.1007/s00415-024-12317.
    PubMed         Abstract available
    
    

    
    J Rheumatol

23. ROBERTS JE, Faino A, Bryan MA, Cogen JD, et al
    Hospitalization and Mortality due to Infection among United States Children and Adolescents with Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Apr 1:jrheum.2023-1219. doi: 10.3899/jrheum.2023-1219.
    PubMed         Abstract available
    
    
24. JUNEK M, Barra L, Kopp A, Felfeli T, et al
    Phase Specific Health Care Costs Associated with Giant Cell Arteritis in Ontario, Canada.
    J Rheumatol. 2024 Apr 1:jrheum.2023-1245. doi: 10.3899/jrheum.2023-1245.
    PubMed         Abstract available
    
    
25. CONTRERAS MARTIN GN
    Lupus Nephritis Treatment Strategies.
    J Rheumatol. 2024 Apr 1:jrheum.2024-0172. doi: 10.3899/jrheum.2024-0172.
    PubMed         Abstract available
    
    
26. OWN M, Bloostein A, Spiera R, Berman JR, et al
    Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series.
    J Rheumatol. 2024;51:390-395.
    PubMed         Abstract available
    
    
27. SEMALULU T, Berard R, Beattie K, Basodan D, et al
    Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry.
    J Rheumatol. 2024;51:403-407.
    PubMed         Abstract available
    
    

    
    Kidney Int

28. BELLUR SS, Troyanov S, Vorobyeva O, Coppo R, et al
    Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Kidney Int. 2024 Mar 28:S0085-2538(24)00235-7. doi: 10.1016/j.kint.2024.
    PubMed         Abstract available
    
    
29. LAFAYETTE R, Barbour S, Israni R, Wei X, et al
    A Phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy.
    Kidney Int. 2024 Mar 27:S0085-2538(24)00236-9. doi: 10.1016/j.kint.2024.
    PubMed         Abstract available
    
    

    
    Mult Scler

30. KWON S, Han KD, Jung JH, Cho EB, et al
    Risk of depression and anxiety in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study in South Korea.
    Mult Scler. 2024 Apr 1:13524585241237093. doi: 10.1177/13524585241237093.
    PubMed         Abstract available
    
    
31. PAPPOLLA A, Auger C, Sao-Aviles A, Tur C, et al
    Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTs.
    Mult Scler. 2024 Mar 29:13524585241240653. doi: 10.1177/13524585241240653.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

32. RAMOS-GONZALEZ EJ, Bitzer-Quintero OK, Ortiz G, Hernandez-Cruz JJ, et al
    Relationship between inflammation and oxidative stress and its effect on multiple sclerosis.
    Neurologia (Engl Ed). 2024;39:292-301.
    PubMed         Abstract available
    
    

    
    Neurology

33. OYAMA M, Holzer MT, Ohnuki Y, Saito Y, et al
    Pathologic Features of Anti-Ku Myositis.
    Neurology. 2024;102:e209268.
    PubMed         Abstract available
    
    

    
    PLoS One

34. IMRAISH A, Abu Thiab T, Alsalem M, Dahbour S, et al
    The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model.
    PLoS One. 2024;19:e0300203.
    PubMed         Abstract available
    
    
35. ESIASON DC, Ciesinski N, Nurse CN, Erler W, et al
    The psychological burden of NMOSD - a mixed method study of patients and caregivers.
    PLoS One. 2024;19:e0300777.
    PubMed         Abstract available
    
    
36. KAMPAITE A, Gustafsson R, York EN, Foley P, et al
    Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review.
    PLoS One. 2024;19:e0299634.
    PubMed         Abstract available
    
    
37. MA J, Xing J, Zhang Y, Liu G, et al
    Efficacy and safety of biologic agents for IgA nephropathy: A protocol for systematic review and meta-analysis.
    PLoS One. 2024;19:e0298732.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.